Welcome to our dedicated page for JELD-WEN Holding SEC filings (Ticker: JELD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on JELD-WEN Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into JELD-WEN Holding's regulatory disclosures and financial reporting.
Wendt Roderick reported acquisition or exercise transactions in this Form 4 filing.
JELD-WEN Holding, Inc. director Roderick Wendt received an equity award of the company’s common stock. He was granted 38,216 restricted stock units at no cost, which are scheduled to vest on May 11, 2027.
Following this grant, Wendt directly holds 118,612 shares of JELD-WEN common stock. He also indirectly holds 284,530 shares through an investment retirement account, the RC Wendt Revocable Trust, and the Roderick Wendt GST Trust, over which he has or shares voting and investment control. Of these, 220,000 shares held in the RC Wendt Revocable Trust are pledged as collateral for a loan.
JELD-WEN Holding, Inc. director David G. Nord reported an equity compensation award rather than an open-market trade. He received a grant of 38,216 shares of common stock in the form of restricted stock units, with no cash price per share shown in the filing. According to the footnote, these restricted stock units will vest on May 11, 2027, meaning the shares are subject to a time-based vesting schedule.
After this award, Nord’s direct holdings of JELD-WEN common stock increased to 113,528 shares. The filing also shows an indirect holding of 40,000 shares by a trust, reported separately. Overall, this Form 4 reflects a compensation-related acquisition of stock units, not a market purchase or sale.
Meier Matthew reported acquisition or exercise transactions in this Form 4 filing.
JELD-WEN Holding, Inc. reported that EVP and Chief Digital & Information Officer Matthew Meier received a grant of 74,522 shares of common stock in the form of restricted stock units as compensation. These units vest in three equal annual installments on May 11, 2027, May 11, 2028, and May 11, 2029, contingent on his continued employment. Following this award, Meier directly holds 127,236 shares of common stock.
Franzen Antonella B reported acquisition or exercise transactions in this Form 4 filing.
JELD-WEN Holding, Inc. director Antonella B. Franzen received a grant of 38,216 shares of Common Stock in the form of restricted stock units at a stated price of $0.00 per share. These units will vest on May 11, 2027. Following this award, she directly holds 84,699 shares.
Marshall Cynthia reported acquisition or exercise transactions in this Form 4 filing.
JELD-WEN Holding, Inc. director Cynthia Marshall received a grant of 38,216 shares of common stock in the form of restricted stock units at no cash cost. After this award, she directly owns 106,027 shares. The restricted stock units are scheduled to vest on May 11, 2027.
JELD-WEN Holding, Inc. director Steven E. Wynne reported an equity award and updated holdings. He received a grant of 38,216 restricted stock units in respect of the company’s common stock at no purchase price, classified as a grant or award acquisition.
Following this award, Wynne directly holds 143,060 shares of common stock, and separately reports 28,000 shares held indirectly as a custodial investment in an IRA. The restricted stock units are scheduled to vest on May 11, 2027, aligning the director’s compensation with the company’s future performance.
Stoddard Samantha reported acquisition or exercise transactions in this Form 4 filing.
JELD-WEN Holding, Inc. reported that EVP & CFO Samantha Stoddard received a grant of 150,955 shares of common stock as an equity award. The grant was made at no cash cost to her and reflects compensation rather than an open-market purchase or sale.
According to the footnote, these restricted stock units will vest in three equal installments on May 11, 2027, May 11, 2028, and May 11, 2029, subject to her continued employment with the company. Following this award, she directly holds 243,394 shares of common stock.
JELD-WEN Holding, Inc. director Bruce M. Taten reported an open-market sale of 19,483 shares of common stock at an average price of $1.6568 per share. According to the footnote, these shares were sold to pay taxes due on the vesting of a restricted stock unit grant originally made on May 8, 2025. After this transaction, Taten directly holds 88,158 shares of JELD-WEN common stock, indicating he retains a substantial equity position following the tax-related sale.
JELD-WEN Holding, Inc. reported a weaker first quarter with lower sales and a continued net loss. Net revenues were $722.1 million versus $776.0 million a year earlier, reflecting softer demand and pricing pressure. The company posted a net loss of $76.8 million, or $(0.90) per share, an improvement from a $190.1 million loss driven previously by large goodwill impairments.
Operating loss narrowed to $55.2 million from $185.0 million, but results were burdened by $12.8 million of legal and professional costs, $8.5 million from a litigation settlement with Steves & Sons, and $2.0 million of restructuring and asset-related charges. Adjusted EBITDA fell to $10.7 million from $26.2 million, with both North America and Europe contributing lower segment profitability.
Cash used in operating activities increased to $91.2 million, reflecting working capital outflows, while capital expenditures were $26.1 million. Total debt stood at $1.22 billion, including $400 million of Senior Notes due 2027 and a $375.5 million term loan, and shareholders’ equity declined to $12.2 million as accumulated deficits and other comprehensive losses increased.